Pathology
 |
|
30 january 2019 18:00:02 |
| Rethinking clinical trial endpoints in myelodysplastic syndromes (Leukemia) |
|
Tweet |
| 78 viewsCategory: Pathology |
 The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1 (Leukemia)New roles for B cell receptor associated kinases: when the B cell is not the target (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
